Atricure, Inc. (ATRC) Tops Q2 EPS by 3c, Boosts FY Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Piper Jaffray Raises Price Target on Atricure, Inc. (ATRC) to $30 Following 2Q Results
July 29, 2015 10:10 AM EDTPiper Jaffray reiterated an Overweight rating on AtriCure Inc. (NASDAQ: ATRC), and raised the price target to $30.00 (from $23.00), following 2Q15 results. ATRC reported Q2 sales of $32.6M, and EPS of -$0.18, beating out consensus on both metrics. Analyst Thomas Gunderson believes that... More
